Murtuza Arsiwalla of Kotak Institutional Equities told CNBC-TV18, "On a valuation basis UltraTech Cement is trading on highly optimistic numbers. If I look at my FY15 numbers I am building fairly optimistically in terms of volume growth at about 6 percent, profitability improvement of 10-15 percent, despite that the stock is trading at almost 10 times on an EV/EBITDA basis, almost 18 times on an earnings basis which is pretty much a stretch."
"We have continued to remain cautious on the stock given that there is a downside risk to our earnings estimates and valuations are very rich on our rather benign assumptions; Rs 1,650 is where we are building in on UltraTech from a 12-month forward perspective."
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!